Jaguar Animal Health (JAGX) Enters $1M Common Stock, Warrants Private Placement
- Indexes hit record highs as Trump rally continues
- Lower for longer, ECB scales back asset buys
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Oil rises above $50 on renewed hopes for output cuts
- LPL Financial (LPLA) Said to Decide to Stay Independent After Reviewing Options - Bloomberg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Jaguar Animal Health, Inc. (Nasdaq: JAGX) announced that it has entered into a definitive agreement to sell securities to certain institutional investors in a private placement for aggregate gross proceeds of approximately $1.0 million before deducting offering expenses payable by Jaguar. The closing is expected to occur on or about November 29, 2016 and is subject to satisfaction of customary closing conditions.
Under the terms of the offering, Jaguar will sell an aggregate of 1,666,668 shares (the “Shares”) of its common stock, par value $0.0001 (the “Common Stock”), at a price of $0.60 per share. The purchasers will also receive (i) warrants to purchase up to an aggregate of 1,666,668 shares of Common Stock at an exercise price of $0.75 per share (the “Series A Warrants”), (ii) warrants to purchase up to an aggregate of 1,666,668 shares of Common Stock at an exercise price of $0.90 per share (the “Series B Warrants”), and (iii) warrants to purchase up to an aggregate of 1,666,668 shares of Common Stock at an exercise price of $1.00 per share (the “Series C Warrants” and collectively with the Series A Warrants and the Series B Warrants, the “Warrants”). The Warrants are not exercisable until 6 months after the date of the closing. From that initial exercisable date, the Series A Warrants will have a term of 5 years, the Series B Warrants will have a term of 6 months, and the Series C Warrants will have a term of 1 year. The potential gross proceeds from the Warrants, if fully exercised on a cash basis, will be approximately $4.4 million.
The Company intends to use the proceeds from the private placement for working capital and general corporate purposes.
Rodman & Renshaw, a unit of H.C. Wainwright & Co., LLC, acted as the exclusive placement agent for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jaguar Animal Health (JAGX) Files 6.67M Common Stock Shelf for Selling Shareholders
- Abbott (ABT) Files Complaint to Terminate Alere (ALR) Acquisition
- Ohr Pharmaceutical (OHRP) to Offer Common Stock